BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund

BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund

Source: 
Pharmaforum
snippet: 

In May, Germany pledged to provide up to €750 million ($889 million) in funding to support vaccines against COVID-19, and the main recipients have now been revealed – BioNTech, CureVac and IDT Biologika – which are all German biotechs.